127
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

4-((5-(1-(4-Fluorophenyl)-5-methyl-1H-1,2,3-triazol-4-yl)-1,3,4-thiadiazol-2-yl)amino)benzenesulfonic acid: unexpected synthesis, structure elucidation and antimicrobial activity

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 10-14 | Received 05 Apr 2022, Accepted 06 Jul 2022, Published online: 15 Jul 2022

References

  • Kaushik, C. P.; Sangwan, J.; Luxmi, R.; Kumar, K.; Pahwa, A. Synthetic Routes for 1,4-Disubstituted 1,2,3-Triazoles: A Review. COC 2019, 23, 860–900. DOI: 10.2174/1385272823666190514074146.
  • Feng, L.-S.; Zheng, M.-J.; Zhao, F.; Liu, D. 1,2,3-Triazole Hybrids with anti-HIV-1 Activity. Arch. Pharm (Weinheim) 2021, 354, e2000163. DOI: 10.1002/ardp.202000163.
  • Bozorov, K.; Zhao, J.; Aisa, H. A. 1,2,3-Triazole-Containing Hybrids as Leads in Medicinal Chemistry: A Recent Overview. Bioorg. Med. Chem. 2019, 27, 3511–3531. DOI: 10.1016/j.bmc.2019.07.005.
  • Varala, R.; Bollikolla, H. B.; Kurmarayuni, C. M. Synthesis of Pharmacological Relevant 1,2,3-Triazole and Its analogues-A Review. Curr. Org. Synth. 2021, 18, 101–124. DOI: 10.2174/1570179417666200914142229.
  • Bonandi, E.; Christodoulou, M. S.; Fumagalli, G.; Perdicchia, D.; Rastelli, G.; Passarella, D. The 1,2,3-Triazole Ring as a Bioisostere in Medicinal Chemistry. Drug Discov. Today 2017, 22, 1572–1581. DOI: 10.1016/j.drudis.2017.05.014.
  • Abdel-Wahab, B. F.; Abdel-Latif, E.; Mohamed, H. A.; Awad, G. E. Design and Synthesis of New 4-Pyrazolin-3-yl-1,2,3-Triazoles and 1,2,3-Triazol-4-yl-Pyrazolin-1-Ylthiazoles as Potential Antimicrobial Agents. Eur. J. Med. Chem. 2012, 52, 263–268. DOI: 10.1016/j.ejmech.2012.03.023.
  • Jain, A. K.; Sharma, S.; Vaidya, A.; Ravichandran, V.; Agrawal, R. K. 1,3,4-thiadiazole and Its Derivatives: A Review on Recent Progress in Biological Activities. Chem. Biol. Drug Des. 2013, 81, 557–576. DOI: 10.1111/cbdd.12125.
  • Serban, G.; Stanasel, O.; Serban, E.; Bota, S. 2-Amino-1,3,4-Thiadiazole as a Potential Scaffold for Promising Antimicrobial Agents. Drug Des. Devel. Ther. 2018, 12, 1545–1566. DOI: 10.2147/DDDT.S155958.
  • Matysiak, J. Biological and Pharmacological Activities of 1,3,4-Thiadiazole Based Compounds. Mini Rev. Med. Chem. 2015, 15, 762–775. DOI: 10.2174/1389557515666150519104057.
  • Hu, Y.; Li, C.-Y.; Wang, X.-M.; Yang, Y.-H.; Zhu, H.-L. 1,3,4-Thiadiazole: synthesis, Reactions, and Applications in Medicinal, Agricultural, and Materials Chemistry. Chem. Rev. 2014, 114, 5572–5610. DOI: 10.1021/cr400131u.
  • Elder, D. P.; Snodin, D. J. Drug Substances Presented as Sulfonic Acid Salts: overview of Utility, Safety and Regulation. J. Pharm. Pharmacol. 2009, 61, 269–278. DOI: 10.1211/jpp/61.03.0001.
  • Elder, D. P.; Delaney, E.; Teasdale, A.; Eyley, S.; Reif, V. D.; Jacq, K.; Facchine, K. L.; Oestrich, R. S.; Sandra, P.; David, F. The Utility of Sulfonate Salts in Drug Development. J. Pharm. Sci. 2010, 99, 2948–2961. DOI: 10.1002/jps.22058.
  • Malarz, K.; Mularski, J.; Kuczak, M.; Mrozek-Wilczkiewicz, A.; Musiol, R. Novel Benzenesulfonate Scaffolds with a High Anticancer Activity and G2/M Cell Cycle Arrest. Cancers 2021, 13, 1790. DOI: 10.3390/cancers13081790.
  • Kariuki, B. M.; Abdel-Wahab, B. F.; El-Hiti, G. A. Synthesis and Structural Characterization of Isostructural 4-(4-Aryl)-2-(5-(4-Fluorophenyl)-3-(1-(4-Fluorophenyl)-5-Methyl-1H-1,2,3-Triazol-4-yl)-4,5-Dihydro-1H-Pyrazol-1-yl)Thiazoles. Crystals 2021, 11, 795. DOI: 10.3390/cryst11070795.
  • Bekheit, M. S.; Mohamed, H. A.; Abdel-Wahab, B. F.; Fouad, M. A. Design and Synthesis of New 1,4,5-Trisubstituted Triazole-Bearing Benzenesulphonamide Moiety as Selective COX-2 Inhibitors. Med. Chem. Res. 2021, 30, 1125–1138. DOI: 10.1007/s00044-021-02716-7.
  • Sert, Y.; El-Hiti, G. A.; Gökce, H.; Ucun, F.; Abdel-Wahab, B. F.; Kariuki, B. M. DFT, Molecular Docking and Experimental FT-IR, laser-Raman, NMR and UV Investigations on a Potential Anticancer Agent Containing Triazole Ring System. J. Mol. Struct. 2020, 1211, 128077. DOI: 10.1016/j.molstruc.2020.128077.
  • Mohamed, H. A.; Khidre, R. E.; Kariuki, B. M.; El-Hiti, G. A. Synthesis of Novel Heterocycles Using 1,2,3-Triazole-4-Carbohydrazides as Precursors. J. Heterocycl. Chem. 2020, 57, 1055–1062. DOI: 10.1002/jhet.3840.
  • Abdel-Wahab, B. F.; Mohamed, H. A.; Awad, G. E. A. Synthesis of 5-(1,2,3-Triazol-4-yl)-1,3,4-Oxa(Thia)Diazol-2-Amines as Antimicrobial Agents. Egypt. J. Chem. 2014, 57, 257–266. DOI: 10.21608/EJCHEM.2014.1044.
  • El-Hiti, G. A.; Abdel-Wahab, B. F.; Hegazy, A. S.; Kariuki, B. M. Crystal Structure of 5-(5-(4-Chlorophenyl)-1-Phenyl-1H-Pyrazol-3-yl)-N-Phenyl-1,3,4-Thiadiazol-2-Amine, C23H16ClN5S. Z. Kristallogr. – New Cryst. Struct. 2017, 232, 317–319. DOI: 10.1515/ncrs-2016-0259.
  • El-Hiti, G. A.; Abdel-Wahab, B. F.; Yousif, E.; Alotaibi, M. H.; Hegazy, A. S.; Kariuki, B. M. N'-[5-Acetyl-3-(4-Chlorophenyl)-2,3-Dihydro-1,3,4-Thiadiazol-2-Ylidene]-5(1H-Indol-3-yl)-1-Phenyl-1H-Pyrazole-3-Carbohydrazide Dimethylformamide Monosolvate. IUCrData 2019, 4, x190148. DOI: 10.1107/S2414314619001482.
  • El-Hiti, G. A.; Abdel-Wahab, B. F.; Yousif, E.; Alotaibi, M. H.; Hegazy, A. S.; Kariuki, B. M. N'-[5-Acetyl-3-(4-Bromophenyl)-2,3-Dihydro-1,3,4-Thiadiazol-2-Ylidene]-5(1H-Indol-3-yl)-1-Phenyl-1H-Pyrazole-3-Carbohydrazide Dimethylformamide Monosolvate. IUCrData 2019, 4, x190248. DOI: 10.1107/S2414314619002487.
  • Abdel-Wahab, B. F.; Alotaibi, M. H.; El-Hiti, G. A. Synthesis of New Symmetrical N,N'-Diacylhydrazines and 2-(1,2,3-Triazol-4-yl)-1,3,4-Oxadiazoles. Lett. Org. Chem. 2017, 14, 591–596. DOI: 10.2174/1570178614666170524130223.
  • Bauer, A. W.; Kirby, W. M.; Sherris, J. C.; Turck, M. Antibiotic Susceptibility Testing by a Standardized Single Disc Method. Am. J. Clin. Pathol. 1966, 45, 493–496. DOI: 10.1093/ajcp/45.4_ts.493.
  • Alvand, Z. M.; Rajabi, H. R.; Mirzaei, A.; Masoumiasl, A. Ultrasonic and Microwave Assisted Extraction as Rapid and Efficient Techniques for Plant Mediated Synthesis of Quantum Dots: green Synthesis, Characterization of Zinc Telluride and Comparison Study of Some Biological Activities. New J. Chem. 2019, 43, 15126–15138. DOI: 10.1039/C9NJ03144H.
  • Hannan, P. C. T. Guidelines and Recommendations for Antimicrobial Minimum Inhibitory Concentration (MIC) Testing against Veterinary Mycoplasma Species. Vet. Res. 2000, 31, 373–395. DOI: 10.1051/vetres:2000100.
  • Sheldrick, G. M. A Short History of SHELX. Acta Crystallogr. 2008, A64, 112–122. DOI: 10.1107/S2053229614024218.
  • Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 2015, 71, 3–8. DOI: 10.1107/S2053229614024218.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.